Clinical trial
Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy ResponSE in Hypogonadal Men (TRAVERSE) Study
NCT03518034 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy ResponSE in Hypogonadal Men (TRAVERSE) Study
- Lead sponsor
- AbbVie
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 3, 2018
- Completion date
- January 19, 2023
- Enrollment
- 5,246 (actual)
- Sites
- 384
Conditions
As the registry lists them; a condition with its own page is linked.